1-3 of 3
Evgenia Xenou
Close
Sort by
Journal Articles

Azacitidine Improves Outcome in Patients with MDS and AML with High Risk Cytogenetics - a Single Center Experience

Vidhya Murthy, MRCP,, Nilupulee Kapuge, Charalampos Kartsios, MD, Joanne Ewing, PhD BMBS, BSc, FRPATH,, Evgenia Xenou, Maria Kaparou, Elmoamly Shereef, Emmanouil Nikolousis
Journal: Blood
Blood (2018) 132 (Supplement 1): 5529.
https://doi.org/10.1182/blood-2018-99-109774
Published: 2018
Journal Articles

Efficacy and Safety of Melphalan 140mg/m 2 Conditioned Autologous Stem Cell Transplantation in Elderly Pre-Dialysis and Dialysis Patients with Multiple Myeloma

Hatem Ali, MBBS, Baharani Jyoti, MBBS, FRCP, Shankaranarayana Paneesha, MD, Richard Lovell, Alex George Kanellopoulos, MD, Evgenia Xenou, MD, Iman Qureshi, MBBS, MRCP, Lorna Cain, Maria Kaparou, David John Sutton, MBBChir, MRCP, BSc, Rebecca Pryor, MB, MRCP, Emmanouil Nikolousis, PhDMBBS,FRCPath,MBA, Bhuvan Kishore, MBBS, MRCP, FRCPath
Journal: Blood
Blood (2016) 128 (22): 5822.
https://doi.org/10.1182/blood.V128.22.5822.5822
Published: 2016
Journal Articles

12-Month Full Donor Chimerism Is Associated with Low-Grade Acute Graft Versus Host Disease (aGVHD) and Predicts Superior Outcomes in Reduced Intensity (RIC) Alemtuzumab-Based Transplants for MDS and AML

Alex George Kanellopoulos, MD, Shankaranarayana Paneesha, MD, Evgenia Xenou, MD, Iman Qureshi, MBBS, MRCP, Dewi Tomos Eden, MRCP,MB,FRCPath, David John Sutton, MBBChir, MRCP, BSc, Rebecca Pryor, MB, MRCP, Lorna Cain, Carolina Arbuthnot, Richard Lovell, Anton Borg, MDFRCP,FRCPath, Katie Randall, MB, FRCPath, Kathy Holder, Julie Suhr, Lynda Baker, Lynn Ryan, Maria Kaparou, Bhuvan Kishore, MBBS, MRCP, FRCPath, Emmanouil Nikolousis, PhD MBBS, FRCPath, MBA
Journal: Blood
Blood (2016) 128 (22): 5764.
https://doi.org/10.1182/blood.V128.22.5764.5764
Published: 2016